Global Transplant Diagnostics Market is expected to grow at a CAGR of 7% during the forecast period. Global Transplant Diagnostics Market is expected to reach US$ 1.47 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
Transplant Diagnostics Market Drivers and Restrains
Transplant diagnostics helps in checking the histocompatibility between patient and donor, which further reduces the chances of organ rejection thereby increasing the reliability of the organ transplantation. The diagnostics devices help to find out the various markers found on the outer surface of cells which regulate the recognition and rejection of foreign body. Technological advancements, rising incidence of chronic diseases, and increased R&D activities are key factors driving the global Transplant Diagnostics market. Increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to drive the transplant diagnostic market in the U.S. during the forecast period. Organ shortage for transplant procedures, challenges in sequencing HLA, treatment cost and lack of awareness are considered to be the major restraint to global market.Transplant Diagnostics Market Key segmentation
Global Transplant Diagnostics Market is segmented by Type and Technology. By type, the market is categorized into solid organ, stem cell, and soft tissue transplantation. Further Solid organ segment is sub-divided in to Lung Transplantation, Liver Transplantation, Kidney Transplantation and Heart Transplantation. The solid organ transplantation segment accounted for the largest share of the market in 2018. Increasing number of solid organ transplantation procedures, supportive government regulations to enhance organ donations across major healthcare markets, and rising number of chronic diseases/disorders that leads to transplantation are the key factors supporting the growth of the market for solid organ transplantation. Based on technology, the market is segmented in to Molecular Assays and Non-Molecular Assays. Molecular assay segment is further sub-categorized in to Sequencing-Based Molecular Assays and PCR-Based Molecular Assays. The molecular assay technology segment is anticipated to hold the largest share of this market thanks to increasing capital for the development of advanced transplant diagnostics products. Market Regional Analysis By region, the global transplant diagnostic market has been categorized as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds largest share of global Transplant Diagnostics market in terms of revenue during forecast period. Because of rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. The market in Asia Pacific is expected to grow at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific whereas the market in India is estimated to expand at a significant CAGR during the forecast period. Increasing awareness as well as affordability of transplantation procedures are factors responsible for growth of transplant diagnostic market in the Asia Pacific. The objective of the report is to present comprehensive analysis of Global Transplant Diagnostics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global Transplant Diagnostics Market dynamics, structure by analyzing the market segments, and project the Global Transplant Diagnostics Market size. Clear representation of competitive analysis of key players by Transplant Diagnostics Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Transplant Diagnostics Market make the report investor’s guide.Scope of Global Transplant Diagnostics Market : Inquire before buying
Global Transplant Diagnostics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 0.91 Bn. Forecast Period 2023 to 2029 CAGR: 7% Market Size in 2029: US $ 1.47 Bn. Segments Covered: by Technology • Molecular Assays • Non-Molecular Assays by Type • Solid Organ Transplantation • Soft Tissue Transplantation • Stem Cell Transplantation by End User • Hospitals & Transplant Centers • Research Laboratories & Academic Institutes • Independent Reference Laboratories • Diagnostic Applications Transplant Diagnostics Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Transplant Diagnostics Market Key Players are:
• Thermo Fisher Scientific, Inc., • Illumina, Inc., • F. Hoffmann La-Roche AG., • Abbott Laboratories, Inc. • Qiagen N.V. • Bio-Rad Laboratories, Inc., • Siemens Healthineers (Siemens AG), • Becton, • Dickinson, and Company, • Immucor, Inc., • Qiagen N.V., • Agilent Technologies • Cylex Inc. • LXN Corporation • Alpha Laboratories • Horiba Medical • Laboratory Corporation of America Holdings • Randox Laboratories Ltd • Thermo Fisher Scientific Inc. • Otsuka Holdings Co Ltd. • Medtronic • Novartis AG • Pfizer Inc. • Sanofi • AbbVie Inc. • Stryker • Zimmer Biomet Frequently Asked questions 1. Which region has the largest share in Global Transplant Diagnostics Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Transplant Diagnostics Market? Ans: The Global Transplant Diagnostics Market is growing at a CAGR of 7% during forecasting period 2023-2029. 3. What is scope of the Global Transplant Diagnostics Market report? Ans: Global Transplant Diagnostics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Transplant Diagnostics Market? Ans: The important key players in the Global Transplant Diagnostics Market are – Cerus Corporation, Fresenius Medical Care, Asahi Kasei Medical, Fenwal, Kawasumi Laboratories, Haemonetics Corporation, Terumo Bct, Kaneka Corporation, Hemacare Corporation, Therakos. 5. What is the study period of this Market? Ans: The Global Transplant Diagnostics Market is studied from 2022 to 2029.
Global Transplant Diagnostics Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Transplant Diagnostics Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Transplant Diagnostics Market Analysis and Forecast 6.1. Global Transplant Diagnostics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Transplant Diagnostics Market Analysis and Forecast, by Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Transplant Diagnostics Market Value Share Analysis, by Technology 7.4. Global Transplant Diagnostics Market Size (US$ Bn) Forecast, by Technology 7.5. Global Transplant Diagnostics Market Analysis, by Technology 7.6. Global Transplant Diagnostics Market Attractiveness Analysis, by Technology 8. Global Transplant Diagnostics Market Analysis and Forecast, by Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Transplant Diagnostics Market Value Share Analysis, by Type 8.4. Global Transplant Diagnostics Market Size (US$ Bn) Forecast, by Type 8.5. Global Transplant Diagnostics Market Analysis, by Type 8.6. Global Transplant Diagnostics Market Attractiveness Analysis, by Type 9. Global Transplant Diagnostics Market Analysis and Forecast, by End-use 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Transplant Diagnostics Market Value Share Analysis, by End-use 9.4. Global Transplant Diagnostics Market Size (US$ Bn) Forecast, by End-use 9.5. Global Transplant Diagnostics Market Analysis, by End-use 9.6. Global Transplant Diagnostics Market Attractiveness Analysis, by End-use 10. Global Transplant Diagnostics Market Analysis, by Region 10.1. Global Transplant Diagnostics Market Value Share Analysis, by Region 10.2. Global Transplant Diagnostics Market Size (US$ Bn) Forecast, by Region 10.3. Global Transplant Diagnostics Market Attractiveness Analysis, by Region 11. North America Transplant Diagnostics Market Analysis 11.1. Key Findings 11.2. North America Transplant Diagnostics Market Overview 11.3. North America Transplant Diagnostics Market Value Share Analysis, by Technology 11.4. North America Transplant Diagnostics Market Forecast, by Technology 11.4.1. Molecular Assays 11.4.2. Non-Molecular Assays 11.5. North America Transplant Diagnostics Market Value Share Analysis, by Type 11.6. North America Transplant Diagnostics Market Forecast, by Type 11.6.1. Solid Organ Transplantation 11.6.2. Soft Tissue Transplantation 11.6.3. Stem Cell Transplantation 11.7. North America Transplant Diagnostics Market Value Share Analysis, by End-use 11.8. North America Transplant Diagnostics Market Forecast, by End-use 11.8.1. Hospitals & Transplant Centers 11.8.2. Research Laboratories & Academic Institutes 11.8.3. Independent Reference Laboratories 11.8.4. Diagnostic Applications 11.9. North America Transplant Diagnostics Market Value Share Analysis, by Country 11.10. North America Transplant Diagnostics Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Transplant Diagnostics Market Analysis, by Country 11.12. U.S. Transplant Diagnostics Market Forecast, by Technology 11.12.1. Molecular Assays 11.12.2. Non-Molecular Assays 11.13. U.S. Transplant Diagnostics Market Forecast, by Type 11.13.1. Solid Organ Transplantation 11.13.2. Soft Tissue Transplantation 11.13.3. Stem Cell Transplantation 11.14. U.S. Transplant Diagnostics Market Forecast, by End-use 11.14.1. Hospitals & Transplant Centers 11.14.2. Research Laboratories & Academic Institutes 11.14.3. Independent Reference Laboratories 11.14.4. Diagnostic Applications 11.15. Canada Transplant Diagnostics Market Forecast, by Technology 11.15.1. Molecular Assays 11.15.2. Non-Molecular Assays 11.16. Steel Canada Transplant Diagnostics Market Forecast, by Type 11.16.1. Solid Organ Transplantation 11.16.2. Soft Tissue Transplantation 11.16.3. Stem Cell Transplantation 11.17. Canada Transplant Diagnostics Market Forecast, by End-use 11.17.1. Hospitals & Transplant Centers 11.17.2. Research Laboratories & Academic Institutes 11.17.3. Independent Reference Laboratories 11.17.4. Diagnostic Applications 11.18. North America Transplant Diagnostics Market Attractiveness Analysis 11.18.1. By Technology 11.18.2. By Type 11.18.3. By End-use 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Transplant Diagnostics Market Analysis 12.1. Key Findings 12.2. Europe Transplant Diagnostics Market Overview 12.3. Europe Transplant Diagnostics Market Value Share Analysis, by Technology 12.4. Europe Transplant Diagnostics Market Forecast, by Technology 12.4.1. Molecular Assays 12.4.2. Non-Molecular Assays 12.5. Europe Transplant Diagnostics Market Value Share Analysis, by Type 12.6. Europe Transplant Diagnostics Market Forecast, by Type 12.6.1. Solid Organ Transplantation 12.6.2. Soft Tissue Transplantation 12.6.3. Stem Cell Transplantation 12.7. Europe Transplant Diagnostics Market Value Share Analysis, by End-use 12.8. Europe Transplant Diagnostics Market Forecast, by End-use 12.8.1. Hospitals & Transplant Centers 12.8.2. Research Laboratories & Academic Institutes 12.8.3. Independent Reference Laboratories 12.8.4. Diagnostic Applications 12.9. Europe Transplant Diagnostics Market Value Share Analysis, by Country 12.10. Europe Transplant Diagnostics Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Transplant Diagnostics Market Analysis, by Country 12.12. Germany Transplant Diagnostics Market Forecast, by Technology 12.12.1. Molecular Assays 12.12.2. Non-Molecular Assays 12.13. Germany Transplant Diagnostics Market Forecast, by Type 12.13.1. Solid Organ Transplantation 12.13.2. Soft Tissue Transplantation 12.13.3. Stem Cell Transplantation 12.14. Germany Transplant Diagnostics Market Forecast, by End-use 12.14.1. Hospitals & Transplant Centers 12.14.2. Research Laboratories & Academic Institutes 12.14.3. Independent Reference Laboratories 12.14.4. Diagnostic Applications 12.15. U.K. Transplant Diagnostics Market Forecast, by Technology 12.15.1. Molecular Assays 12.15.2. Non-Molecular Assays 12.16. U.K. Transplant Diagnostics Market Forecast, by Type 12.16.1. Solid Organ Transplantation 12.16.2. Soft Tissue Transplantation 12.16.3. Stem Cell Transplantation 12.17. U.K. Transplant Diagnostics Market Forecast, by End-use 12.17.1. Hospitals & Transplant Centers 12.17.2. Research Laboratories & Academic Institutes 12.17.3. Independent Reference Laboratories 12.17.4. Diagnostic Applications 12.18. France Transplant Diagnostics Market Forecast, by Technology 12.18.1. Molecular Assays 12.18.2. Non-Molecular Assays 12.19. France Transplant Diagnostics Market Forecast, by Type 12.19.1. Solid Organ Transplantation 12.19.2. Soft Tissue Transplantation 12.19.3. Stem Cell Transplantation 12.20. France Transplant Diagnostics Market Forecast, by End-use 12.20.1. Hospitals & Transplant Centers 12.20.2. Research Laboratories & Academic Institutes 12.20.3. Independent Reference Laboratories 12.20.4. Diagnostic Applications 12.21. Italy Transplant Diagnostics Market Forecast, by Technology 12.21.1. Molecular Assays 12.21.2. Non-Molecular Assays 12.22. Italy Transplant Diagnostics Market Forecast, by Type 12.22.1. Solid Organ Transplantation 12.22.2. Soft Tissue Transplantation 12.22.3. Stem Cell Transplantation 12.23. Italy Transplant Diagnostics Market Forecast, by End-use 12.23.1. Hospitals & Transplant Centers 12.23.2. Research Laboratories & Academic Institutes 12.23.3. Independent Reference Laboratories 12.23.4. Diagnostic Applications 12.24. Spain Transplant Diagnostics Market Forecast, by Technology 12.24.1. Molecular Assays 12.24.2. Non-Molecular Assays 12.25. Spain Transplant Diagnostics Market Forecast, by Type 12.25.1. Solid Organ Transplantation 12.25.2. Soft Tissue Transplantation 12.25.3. Stem Cell Transplantation 12.26. Spain Transplant Diagnostics Market Forecast, by End-use 12.26.1. Hospitals & Transplant Centers 12.26.2. Research Laboratories & Academic Institutes 12.26.3. Independent Reference Laboratories 12.26.4. Diagnostic Applications 12.27. Rest of Europe Transplant Diagnostics Market Forecast, by Technology 12.27.1. Molecular Assays 12.27.2. Non-Molecular Assays 12.28. Rest of Europe Transplant Diagnostics Market Forecast, by Type 12.28.1. Solid Organ Transplantation 12.28.2. Soft Tissue Transplantation 12.28.3. Stem Cell Transplantation 12.29. Rest Of Europe Transplant Diagnostics Market Forecast, by End-use 12.29.1. Hospitals & Transplant Centers 12.29.2. Research Laboratories & Academic Institutes 12.29.3. Independent Reference Laboratories 12.29.4. Diagnostic Applications 12.30. Europe Transplant Diagnostics Market Attractiveness Analysis 12.30.1. By Technology 12.30.2. By Type 12.30.3. By End-use 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Transplant Diagnostics Market Analysis 13.1. Key Findings 13.2. Asia Pacific Transplant Diagnostics Market Overview 13.3. Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technology 13.4. Asia Pacific Transplant Diagnostics Market Forecast, by Technology 13.4.1. Molecular Assays 13.4.2. Non-Molecular Assays 13.5. Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Type 13.6. Asia Pacific Transplant Diagnostics Market Forecast, by Type 13.6.1. Solid Organ Transplantation 13.6.2. Soft Tissue Transplantation 13.6.3. Stem Cell Transplantation 13.7. Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-use 13.8. Asia Pacific Transplant Diagnostics Market Forecast, by End-use 13.8.1. Hospitals & Transplant Centers 13.8.2. Research Laboratories & Academic Institutes 13.8.3. Independent Reference Laboratories 13.8.4. Diagnostic Applications 13.9. Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country 13.10. Asia Pacific Transplant Diagnostics Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Transplant Diagnostics Market Analysis, by Country 13.12. China Transplant Diagnostics Market Forecast, by Technology 13.12.1. Molecular Assays 13.12.2. Non-Molecular Assays 13.13. China Transplant Diagnostics Market Forecast, by Type 13.13.1. Solid Organ Transplantation 13.13.2. Soft Tissue Transplantation 13.13.3. Stem Cell Transplantation 13.14. China Transplant Diagnostics Market Forecast, by End-use 13.14.1. Hospitals & Transplant Centers 13.14.2. Research Laboratories & Academic Institutes 13.14.3. Independent Reference Laboratories 13.14.4. Diagnostic Applications 13.15. India Transplant Diagnostics Market Forecast, by Technology 13.15.1. Molecular Assays 13.15.2. Non-Molecular Assays 13.16. India Transplant Diagnostics Market Forecast, by Type 13.16.1. Solid Organ Transplantation 13.16.2. Soft Tissue Transplantation 13.16.3. Stem Cell Transplantation 13.17. India Transplant Diagnostics Market Forecast, by End-use 13.17.1. Hospitals & Transplant Centers 13.17.2. Research Laboratories & Academic Institutes 13.17.3. Independent Reference Laboratories 13.17.4. Diagnostic Applications 13.18. Japan Transplant Diagnostics Market Forecast, by Technology 13.18.1. Molecular Assays 13.18.2. Non-Molecular Assays 13.19. Japan Transplant Diagnostics Market Forecast, by Type 13.19.1. Solid Organ Transplantation 13.19.2. Soft Tissue Transplantation 13.19.3. Stem Cell Transplantation 13.20. Japan Transplant Diagnostics Market Forecast, by End-use 13.20.1. Hospitals & Transplant Centers 13.20.2. Research Laboratories & Academic Institutes 13.20.3. Independent Reference Laboratories 13.20.4. Diagnostic Applications 13.21. ASEAN Transplant Diagnostics Market Forecast, by Technology 13.21.1. Molecular Assays 13.21.2. Non-Molecular Assays 13.22. ASEAN Transplant Diagnostics Market Forecast, by Type 13.22.1. Solid Organ Transplantation 13.22.2. Soft Tissue Transplantation 13.22.3. Stem Cell Transplantation 13.23. ASEAN Transplant Diagnostics Market Forecast, by End-use 13.23.1. Hospitals & Transplant Centers 13.23.2. Research Laboratories & Academic Institutes 13.23.3. Independent Reference Laboratories 13.23.4. Diagnostic Applications 13.24. Rest of Asia Pacific Transplant Diagnostics Market Forecast, by Technology 13.24.1. Molecular Assays 13.24.2. Non-Molecular Assays 13.25. Rest of Asia Pacific Transplant Diagnostics Market Forecast, by Type 13.25.1. Solid Organ Transplantation 13.25.2. Soft Tissue Transplantation 13.25.3. Stem Cell Transplantation 13.26. Rest of Asia Pacific Transplant Diagnostics Market Forecast, by End-use 13.26.1. Hospitals & Transplant Centers 13.26.2. Research Laboratories & Academic Institutes 13.26.3. Independent Reference Laboratories 13.26.4. Diagnostic Applications 13.27. Asia Pacific Transplant Diagnostics Market Attractiveness Analysis 13.27.1. By Technology 13.27.2. By Type 13.27.3. By End-use 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Transplant Diagnostics Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Transplant Diagnostics Market Overview 14.3. Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technology 14.4. Middle East & Africa Transplant Diagnostics Market Forecast, by Technology 14.4.1. Molecular Assays 14.4.2. Non-Molecular Assays 14.5. Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Type 14.6. Middle East & Africa Transplant Diagnostics Market Forecast, by Type 14.6.1. Solid Organ Transplantation 14.6.2. Soft Tissue Transplantation 14.6.3. Stem Cell Transplantation 14.7. Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-use 14.8. Middle East & Africa Transplant Diagnostics Market Forecast, by End-use 14.8.1. Hospitals & Transplant Centers 14.8.2. Research Laboratories & Academic Institutes 14.8.3. Independent Reference Laboratories 14.8.4. Diagnostic Applications 14.9. Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country 14.10. Middle East & Africa Transplant Diagnostics Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Transplant Diagnostics Market Analysis, by Country 14.12. GCC Transplant Diagnostics Market Forecast, by Technology 14.12.1. Molecular Assays 14.12.2. Non-Molecular Assays 14.13. GCC Transplant Diagnostics Market Forecast, by Type 14.13.1. Solid Organ Transplantation 14.13.2. Soft Tissue Transplantation 14.13.3. Stem Cell Transplantation 14.14. GCC Transplant Diagnostics Market Forecast, by End-use 14.14.1. Hospitals & Transplant Centers 14.14.2. Research Laboratories & Academic Institutes 14.14.3. Independent Reference Laboratories 14.14.4. Diagnostic Applications 14.15. South Africa Transplant Diagnostics Market Forecast, by Technology 14.15.1. Molecular Assays 14.15.2. Non-Molecular Assays 14.16. South Africa Transplant Diagnostics Market Forecast, by Type 14.16.1. Solid Organ Transplantation 14.16.2. Soft Tissue Transplantation 14.16.3. Stem Cell Transplantation 14.17. South Africa Transplant Diagnostics Market Forecast, by End-use 14.17.1. Hospitals & Transplant Centers 14.17.2. Research Laboratories & Academic Institutes 14.17.3. Independent Reference Laboratories 14.17.4. Diagnostic Applications 14.18. Rest of Middle East & Africa Transplant Diagnostics Market Forecast, by Technology 14.18.1. Molecular Assays 14.18.2. Non-Molecular Assays 14.19. Rest of Middle East & Africa Transplant Diagnostics Market Forecast, by Type 14.19.1. Solid Organ Transplantation 14.19.2. Soft Tissue Transplantation 14.19.3. Stem Cell Transplantation 14.20. Rest of Middle East & Africa Transplant Diagnostics Market Forecast, by End-use 14.20.1. Hospitals & Transplant Centers 14.20.2. Research Laboratories & Academic Institutes 14.20.3. Independent Reference Laboratories 14.20.4. Diagnostic Applications 14.21. Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis 14.21.1. By Technology 14.21.2. By Type 14.21.3. By End-use 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Transplant Diagnostics Market Analysis 15.1. Key Findings 15.2. South America Transplant Diagnostics Market Overview 15.3. South America Transplant Diagnostics Market Value Share Analysis, by Technology 15.4. South America Transplant Diagnostics Market Forecast, by Technology 15.4.1. Molecular Assays 15.4.2. Non-Molecular Assays 15.5. South America Transplant Diagnostics Market Value Share Analysis, by Type 15.6. South America Transplant Diagnostics Market Forecast, by Type 15.6.1. Solid Organ Transplantation 15.6.2. Soft Tissue Transplantation 15.6.3. Stem Cell Transplantation 15.7. South America Transplant Diagnostics Market Value Share Analysis, by End-use 15.8. South America Transplant Diagnostics Market Forecast, by End-use 15.8.1. Hospitals & Transplant Centers 15.8.2. Research Laboratories & Academic Institutes 15.8.3. Independent Reference Laboratories 15.8.4. Diagnostic Applications 15.9. South America Transplant Diagnostics Market Value Share Analysis, by Country 15.10. South America Transplant Diagnostics Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Transplant Diagnostics Market Analysis, by Country 15.12. Brazil Transplant Diagnostics Market Forecast, by Technology 15.12.1. Molecular Assays 15.12.2. Non-Molecular Assays 15.13. Brazil Transplant Diagnostics Market Forecast, by Type 15.13.1. Solid Organ Transplantation 15.13.2. Soft Tissue Transplantation 15.13.3. Stem Cell Transplantation 15.14. Brazil Transplant Diagnostics Market Forecast, by End-use 15.14.1. Hospitals & Transplant Centers 15.14.2. Research Laboratories & Academic Institutes 15.14.3. Independent Reference Laboratories 15.14.4. Diagnostic Applications 15.15. Mexico Transplant Diagnostics Market Forecast, by Technology 15.15.1. Molecular Assays 15.15.2. Non-Molecular Assays 15.16. Mexico Transplant Diagnostics Market Forecast, by Type 15.16.1. Solid Organ Transplantation 15.16.2. Soft Tissue Transplantation 15.16.3. Stem Cell Transplantation 15.17. Mexico Transplant Diagnostics Market Forecast, by End-use 15.17.1. Hospitals & Transplant Centers 15.17.2. Research Laboratories & Academic Institutes 15.17.3. Independent Reference Laboratories 15.17.4. Diagnostic Applications 15.18. Rest of South America Transplant Diagnostics Market Forecast, by Technology 15.18.1. Molecular Assays 15.18.2. Non-Molecular Assays 15.19. Rest of South America Transplant Diagnostics Market Forecast, by Type 15.19.1. Solid Organ Transplantation 15.19.2. Soft Tissue Transplantation 15.19.3. Stem Cell Transplantation 15.20. Rest of South America Transplant Diagnostics Market Forecast, by End-use 15.20.1. Hospitals & Transplant Centers 15.20.2. Research Laboratories & Academic Institutes 15.20.3. Independent Reference Laboratories 15.20.4. Diagnostic Applications 15.21. South America Transplant Diagnostics Market Attractiveness Analysis 15.21.1. By Technology 15.21.2. By Type 15.21.3. By End-use 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Thermo Fisher Scientific, Inc., 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Illumina, Inc., 16.3.3. F. Hoffmann La-Roche AG., 16.3.4. Abbott Laboratories, Inc. 16.3.5. Qiagen N.V. 16.3.6. Bio-Rad Laboratories, Inc., 16.3.7. Siemens Healthineers (Siemens AG), 16.3.8. Becton, 16.3.9. Dickinson, and Company, 16.3.10. Immucor, Inc., 16.3.11. Qiagen N.V., 16.3.12.Laboratory Corporation of America Holdings, 16.3.13. Agilent Technologies 16.3.13. Cylex Inc. 16.3.14. LXN Corporation 16.3.15. Alpha Laboratories 16.3.16. Horiba Medical 16.3.17. Randox Laboratories Ltd 16.3.18. Thermo Fisher Scientific Inc. 16.3.19. Otsuka Holdings Co Ltd. 16.3.20. Medtronic 16.3.21. Novartis AG 16.3.22. Pfizer Inc. 16.3.23. Sanofi 16.3.24. AbbVie Inc. 16.3.25. Stryker 16.3.26. Zimmer Biomet 17. Primary Key Insights